Yesterday, startup LifePlus exited stealth mode to reveal what it claims to be the first noninvasive continuous blood glucose monitoring multi-sensor wearable, called LifeLeaf. Although details are scare on exactly how the technology works, the company said the product is being tested in five clinical trials around the world.
“We have been in stealth mode and today we are thrilled to announce...
